Von Eschenbach closer to approval as FDA head; CMS Administrator McClellan departing

From: Formulary | Date: October 1, 2006| Author: Nagy, Benjamin | Copyright information

FEDERAL AND STATE GOVERNMENT ACTIONS AND THEIR IMPACT ON DRUG DECISION-MAKERS

Although acting FDA Commissioner Andrew von Eschenbuch, MD, has been on the job since September 2005, it was only last month that he received approval from the Senate's Health, Education. Labor and Pension (HELP) committee tor his nomination us FDA commissioner to he considered by the full Senate. However, the step was an incremental one at best for Dr von Eschenbach and the agency, which has been without an ...